This study examined a dataset of 20,338 participants, followed for an average of 13.2 years, and found that fish oil supplementation was associated with a 10% reduction in risk of macrovascular outcomes and an 11% risk reduction in microvascular outcomes
Opportunity Growing Research and Development The future of the GLP-1 receptor agonist market is promising, driven by growing research and development activities
and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls
This naming convention serves several important functions in the healthcare system and pharmaceutical industry
How Long Before You Notice Changes
With innovation spanning long-acting injectables, oral GLP-1s, and dual agonist combinations, pharmaceutical leaders are accelerating next-generation treatment accessibility and patient convenience